[HTML][HTML] Natural products in non-alcoholic fatty liver disease (NAFLD): Novel lead discovery for drug development
L Wang, Y Yan, L Wu, J Peng - Pharmacological Research, 2023 - Elsevier
With changing lifestyles, non-alcoholic fatty liver disease (NAFLD) has become the most
prevalent liver disease worldwide. A substantial increase in the incidence, mortality, and …
prevalent liver disease worldwide. A substantial increase in the incidence, mortality, and …
The metabolic syndrome, a human disease
M Alemany - International journal of molecular sciences, 2024 - mdpi.com
This review focuses on the question of metabolic syndrome (MS) being a complex, but
essentially monophyletic, galaxy of associated diseases/disorders, or just a syndrome of …
essentially monophyletic, galaxy of associated diseases/disorders, or just a syndrome of …
Predictive Value of the Chinese Visceral Adiposity Index for Metabolic Dysfunction-Associated Fatty Liver Disease and Elevated Alanine Aminotransferase Levels in …
Z Niu, J Chen, H Wang, R Wang, H Peng… - Journal of …, 2024 - Taylor & Francis
Purpose It is unclear how the Chinese Visceral Adiposity Index (cVAI) relates to metabolic
dysfunction-associated fatty liver disease (MAFLD) and alanine aminotransferase (ALT) in …
dysfunction-associated fatty liver disease (MAFLD) and alanine aminotransferase (ALT) in …
Risk of severe infection in patients with non‐alcoholic fatty liver disease: Implication on clinical management
Non-alcoholic fatty liver disease (NAFLD), recently renamed metabolic dysfunction-
associated steatotic liver disease (MASLD), is currently affecting 30% of the global adult …
associated steatotic liver disease (MASLD), is currently affecting 30% of the global adult …